跳至主要内容
临床试验/CTRI/2021/08/035591
CTRI/2021/08/035591尚未招募不适用

To study the effect of Ushiraadi anjana & Dwitiya Triphaladi ghrita pana in Timira(Presbyopia)

Rishikul campus Haridwar UAU1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年8月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Near vision improvement

研究概览

简要总结

The Clinical study will be conducted with aim to provide a better treatment approach to patients of Dwitiya Patalagata Timira ( Presbyopia). In this clinical study Ushiraadi Anjana & Dwitiya Triphaladi Ghrita pana will be administered to the patients selected randomly for clinical trial.  Total 40 patients fulfilling the inclusion & exclusion criteria will be registered in a single group for this study from OPD/IPD of P.G department of Shalakya Tantra, Rishikul campus, Haridwar. Uttarakhand Ayurved University.A detailed proforma will be prepared on the basis of Ayurvedic texts & allied science.The scoring of different clinical features will be done on the basis of different assessment criterian.  After completion of 45 days trial, 2 follow ups will be done at intervals of 1 month.The different tables of scores obtained before & after treatment will be prepared for the comparison & statistical analysis will be done by applying suitable tests.The inference will be made on the basis of statistically analysed data.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
35.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients presenting with clinical features of Dwitiya patalagata timira(Presbyopia)
  • Patients between age group of 35-55 years
  • Patients having near visual acuity < N6 or N6 with strain
  • Patient having distant vision 6/6 or best corrected distant vision.

排除标准

  • 1.Tritiya & Chaturtha patalagata Timira.
  • 2.Patient with infective anterior segment disease & any other ocular pathologies like cataract, glaucoma & retinal pathologies.
  • 3.Patients who have underwent any of the ocular surgeries 4.patients suffering from any of the systemic disorders (Hypertension, diabetes,dislipidemia).

结局指标

主要结局

Near vision improvement

时间窗: at 1st day, 25th day, 45th day

次要结局

  • Relief in other signs & symptoms of Presbyopia(1st day , 25th day , 45th day)

研究者

发起方
Rishikul campus Haridwar UAU
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验